Sean M. Hays - Concepedia

Author

Sean M. Hays

Summit School ORCID

Also Known As

Hays, Sean, S M Hays, S. Hays, S. M. Hays, S.M. Hays, SEAN M HAYS, Sean Hays, Sean M Hays, Sean M. Hays, Sophie Hays

161

Publications

6.1K

Citations

H-Index

124

Concepts

All Affiliations

Summit School Health Canada Université de Montréal Environmental Protection Agency Dow Chemical (United States)

About

Sean M. Hays is an author at Summit School specializing in medicine, toxicology, and environmental toxicology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	45	2.4K
2	Engineering	15	17	1K
3	Management	3	3	50
4	Health Sciences	1	1	39
5	Natural Sciences	1	1	62

Sean M. Hays

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Incorporating New Technologies Into Toxicity Testing and Risk Assessment: Moving From 21st Century Vision to a Data-Driven Framework Russell S. Thomas, Martin A. Philbert, Scott S. Auerbach, Toxicological Sciences Physiologically-based Pharmacokinetic ModelingEnvironmental Health21St Century VisionToxicologyBiostatistics	2013	268
Guidelines for the derivation of Biomonitoring Equivalents: Report from the Biomonitoring Equivalents Expert Workshop Sean M. Hays, Lesa L. Aylward, Judy S. LaKind, Regulatory Toxicology and Pharmacology EngineeringBioenergeticsBiosystems EngineeringBioanalysisAnalytical Chemistry	2008	173
Guidelines for the communication of Biomonitoring Equivalents: Report from the Biomonitoring Equivalents Expert Workshop Judy S. LaKind, Lesa L. Aylward, Conrad Brunk, Regulatory Toxicology and Pharmacology EngineeringBioimpedance SensorsBiosystems EngineeringBioanalysisBiostatistics	2008	169
Evaluation of Biomonitoring Data from the CDC National Exposure Report in a Risk Assessment Context: Perspectives across Chemicals Lesa L. Aylward, Christopher R. Kirman, Rita Schoeny, Environmental Health Perspectives	2012	161
Characterizing Uncertainty and Variability in Physiologically Based Pharmacokinetic Models: State of the Science and Needs for Research and Implementation Hugh A. Barton, Weihsueh A. Chiu, R. Woodrow Setzer, Toxicological Sciences Drug SafetyPhysiologically Based PharmacokineticsPharmacokinetic ModelingPharmacodynamicsInternal Dosimetry	2007	143
Concentration-dependent TCDD elimination kinetics in humans: toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort Lesa L. Aylward, Robert C. Brunet, Gaétan Carrier, Journal of Exposure Science & Environmental Epidemiology Toxicokinetic ModelingEnvironmental ExposureMedicineEnvironmental HealthForensic Toxicology	2004	141
A chronic oral reference dose for hexavalent chromium‐induced intestinal cancer Chad M. Thompson, Christopher R. Kirman, Deborah M. Proctor, Journal of Applied Toxicology	2013	133
Temporal trends in human TCDD body burden: Decreases over three decades and implications for exposure levels Lesa L. Aylward, Sean M. Hays Journal of Exposure Science & Environmental Epidemiology Exposure LevelsHealth EffectBody CompositionOccupational Health SciencesTemporal Trends	2002	116
Variation in Urinary Flow Rates According to Demographic Characteristics and Body Mass Index in NHANES: Potential Confounding of Associations between Health Outcomes and Urinary Biomarker Concentrations Sean M. Hays, Lesa L. Aylward, Benjamin C. Blount Environmental Health Perspectives	2015	113
Inter- and intra-individual variation in urinary biomarker concentrations over a 6-day sampling period. Part 2: Personal care product ingredients Holger M. Koch, Lesa L. Aylward, Sean M. Hays, Toxicology Letters Biomarker (Medicine)UrologyBioanalysis6-Day Sampling PeriodIntra-individual Variation	2014	112

Page 1